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ABSTRACT
Small extracellular vesicles (EVs) are membrane enclosed structures that are usually released from
cells upon exocytosis of multivesicular bodies (MVBs) as a collection of separate, free EVs. In this study,
we analysed paraffin embedded sections of archived human colorectal cancer samples. We studied
3D reconstructions of confocal microscopic images complemented by HyVolution and STED imaging.
Unexpectedly, we found evidence that large, MVB-like aggregates of ALIX/CD63 positive EV clusters
were released en bloc bymigrating tumour cells. These structures were often captured with partial or
complete extra-cytoplasmic localization at the interface of the plasma membrane of the tumour cell
and the stroma. Their diameter ranged between 0.62 and 1.94 μm (mean±S.D.: 1.17 ± 0.34 μm). High-
resolution 3D reconstruction showed that these extracellular MVB-like EV clusters were composed of
distinguishable internal particles of small EV size (mean±S.D.: 128.96 ± 16.73 nm). In vitro, HT29
colorectal cancer cells also showed the release of similar structures as confirmed by immunohisto-
chemistry and immune electronmicroscopy. Our results provide evidence for an en bloc transmission
of MVB-like EV clusters through the plasma membrane. Immunofluorescent-based detection of the
MVB like small EV clusters in archived pathological samples may represent a novel and unique
opportunity which enables analysis of EV release in situ in human tissues.
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Introduction
Beside soluble mediators, cancer-stroma interactions
also involve extracellular vesicles (EVs) that mediate
complex biological information transfer via proteins,
nucleic acids, lipids and metabolites. Small (< 200 nm
diameter) EVs (sEVs) are typically released by the
exocytosis of multivesicular bodies (MVBs) [1,2].
During the MVB exocytosis, separate, individual sEVs
are considered to be released into the extracellular
space, which cannot be resolved using conventional
confocal microscopy limited by the light diffraction at
~250 nm [3]. Besides MVB exocytosis, cells can also
release EVs (typically medium and large EVs) by
budding of the plasma membrane [4,5]. Recent reports
described the release of large, MVB like structures such
as migrasomes [6], Nef protein-induced plasma mem-
brane protrusions giving rise to released EV clusters
[7], multivesicular spheres [8] and released multivesi-
cular cargo [9]. These recent studies suggest that the
examined cells can release sEV clusters (sEVCs).
Here we describe for the first time the release of
ALG 2-interacting protein X (ALIX)/CD63 [1] posi-
tive MVB-like sEVC in formalin-fixed, paraffin-
embedded (FFPE) tissue samples of colorectal carci-
noma (CRC) patients as well as in in vitro cultures of
HT29 CRC cells.
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Materials and methods
Tissue samples
Surgically removed FFPE samples (fixed with 10% neu-
tral buffered formalin) from metastatic CRC samples
were embedded into tissue microarray (TMA) blocks
(core diameter: 2 mm). We examined serial sections of
two different tissue blocks from 31 CRC patients
(Σ = 62 TMAs). The patients included 15 Dukes
C patients (3 women (w)/12 men (m); mean age±S.D.:
58.20 ± 7.25 years; age range: 48–70 years) and 16 Dukes
D ones (7w/9m; mean age±S.D.: 64.56 ± 8.37 years; age
range: 51–80 years) (according to Astler-Coller-modified
Dukes’ classification). Diagnoses were established on the
basis of WHO criteria using H&E-stained serial sections
by an expert pathologist [10]. This study was approved
by the Semmelweis University Regional and Institutional
Committee of Science and Research Ethics: ETT TUKEB
23,970/2011 and 8–23/2009–1018 EKU (ad.60/PI/09).
Cell culture
HT29 human colorectal cancer cells (ATTC_HTB-38)
were grown in triplicates for 24 h on 8-well Nunc Lab-
Tek (177,402, Nagle Nunc, Rochester, USA) for con-
focal microscopy and 8-well Ibitreat microscopy cham-
ber (Ibidi GmbH, Martinsried, German) for STED
microscopy (initial cell number: 5000 cell/300 µl/
well). For electron microscopy (EM) and DAB immune
EM, we cultured the cells on Lab-Tek chamber (initial
cell number: 8000 cell/300 µl/well) for 72 h in RPMI
1640 medium (Biosera, Ringmer, UK) supplemented
with 2 mM L-glutamine (Merck-Sigma-Aldrich,
Darmstadt, Germany), 80 mg/2 ml gentamycin
(Sandoz) and 10% sEV-depleted FBS. To preserve the
MVB-like sEVCs, we decanted the culture medium
carefully from the cultures, instead of aspirating it
with a pipette. The sEV depletion was performed by
ultracentrifugation of foetal bovine serum (Merck-
Sigma-Aldrich, Darmstadt, Germany) in an Optima
MAX-XP Benchtop Ultracentrifuge with an MLA-55
fixed-angle rotor (Beckman Coulter, Brea, USA) at
120,000 g for 16 h.
Isolation of MVB-like sEVCs from HT29 culture
supernatant
Twenty-four hours conditioned medium samples of
HT29 cells were decanted from the cell cultures and
paraformaldehyde (PFA) was added to 4% final con-
centration. After 10 min at room temperature, 0.25%
glutaraldehyde was added, and the samples were cen-
trifug4ed at 2,000 g for 10 min. The pellet washed once
with filtered 0.9% NaCl solution, and re-pelleted at
2,000 g for 10 min. Finally, the supernatant was
removed carefully and 4% PFA in PBS was layered on
top of the pellet.
Immunohistochemistry
FFPE TMA blocks and cultures of HT29 cells were
immunostained using fluorochrome conjugated anti-
bodies. Cell cultures were washed in TBS and fixed
either with methanol and acetone (1:1), or in 4% neu-
tral buffered formaldehyde (made from PFA), for
10 min. The latter samples were permeabilized TBS
containing 0.2% Triton-X-100 (TBST) for 10 min.
TMA sections mounted on adhesive glass slides
(SuperFrost Plus, Thermo-Fisher) were dewaxed and
treated for endogenous peroxidase blocking using 0.5%
hydrogen peroxide in methanol for 20 min. Antigen
retrieval was performed by heating dewaxed paraffin
sections in 0.01M Tris-0.1M EDTA buffer pH 9.0 (TE)
at ~100°C for 40 min in a JT 366 microwave oven
(Whirlpool, Benton Harbor, MI). Nonspeciﬁc binding
sites in cells and tissue sections were saturated using
5% BSA-TBST solution for 30 min. Antibodies specific
for sEV markers ALIX (HPA011905, Sigma Aldrich, St
Louis, USA; 1:400) and CD63 (NKI/C3, Leica-
Novocastra, Wetzlar, Germany; 1:50), and LC3B
(NB100-2220, Novus Biologicals, Centennial,
Colorado, 1:200) proteins were used. Detection of
RAB7 (R8779, Sigma Aldrich; St. Louis, MO, 1:200)
protein. Pan-cytokeratin (AE1/AE3 from Dako,
Glostrup, Denmark; 1:100) and cytokeratin 18 (Alexa
Fluor 488-labelled, 18–0059 from Life Technologies,
Grand Island, NY) antibodies were used to confirm
the epithelial origin of cancer cells. Cell membrane
E-cadherin was also immunostained using clones
EP700Y and 36B5 (Thermo-LabVision, Fremont, CA;
1:100). Primary antibodies were detected using anti-
rabbit or anti-mouse immunoglobulins conjugated
with either Alexa Fluor 488, 546 or 514 (Life
Technologies) in relevant combinations. The specificity
of our EV markers was confirmed by detecting the co-
localization of CD81 (SAB3500454, Sigma Aldrich;
1:200) and LAMP1 (FNab04684, Wuhan Fine Biotech,
Wuhan, China; 1:100) proteins using polyclonal rabbit
antibodies (Supplementary Figure 1). In these cases,
the immunoperoxidase-based TSA (tyramide signal
amplification) Plus system (Perkin-Elmer, Shelton,
CT) was used, which allow double labelling combining
antibodies from the same species, including FITC
(green) and rhodamine (red) conjugated tyramide
reagents for antigen demonstration.
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The 2,000 g EV fractions were fixed with 4% PFA
(20 min) and blocked with 10% FBS in PBS (60ʹ).
Primary antibodies for RAB7 and LC3B were applied in
1:200 dilution using 10% FBS in PBS (4°C, overnight).
After washing steps, donkey anti-mouse IgG conjugated
with CF488A (Sigma Aldrich) and goat anti-rabbit IgG
conjugated with Atto 647N (Sigma Aldrich) were used
(1:400) in PBS containing 1% FBS (60ʹ). All incubations
were done at room temperature (RT), where samples
were washed using TBS (ph 7.4). Following washing,
samples were mounted with ProLong Diamond
Antifade Mountant (Life Technologies).
Microscopy
Slides were digitalized with Pannoramic Confocal
instrument and were analysed (including morpho-
metric measurements and counting intra and extracel-
lular signals) with Pannoramic Viewer (v: 1.15.3)
digital microscope (3DHISTECH, Budapest,
Hungary). Three-dimensional (3D) reconstructions
were performed with the Voloom software (v: 2.7.1;
MicroDimensions, Munich, Germany) after combining
9 Z-axial confocal layers of 0.4 μm focus steps, which
incorporated ~Σ = 3.6 μm section thickness. For better
visibility of the fluorescent signals, contrast/brightness
were edited by Microsoft PowerPoint for the entire
images of Figure 3(h–j), and the Supplementary
Figure 1. The HyVolution [11] and the stimulated
emission depletion (STED) imaging was performed
on a Leica TCS SP8 STED microscope using Leica
HC PL APO ×100 (NA = 1.4) objective. For STED
imaging, 660 nm depletion laser was applied. The
images were restored by using Huygens Pro deconvo-
lution, and were analysed with Leica LAS X 3.1.1 soft-
ware. Quantitative image analysis was performed with
the Marker Counter tool of the digital microscope. The
2,000 g EV preparations were examined by a Nikon
Eclipse 80i epifluorescence microscope. We used t test
to compare of examined parameters.
Electron microscopy and immune electron
microscopy
a. In the case of ultrastructural studies without immu-
nostaining, after rinsing with PBS, the cells were post-
ﬁxed in 1% OsO4 for 15 min, rinsed with distilled water,
dehydrated in graded ethanol including block-staining
with 1% uranyl acetate in 50% ethanol for 15 min and
embedded in Taab 812 (Aldermaston, T031).
b. Immunostaining for ALIX (HPA011905, rabbit,
1:400) was performed in situ on Lab-Tek chamber
slides. The fixed HT29 cells were washed in PBS (pH
7.4), then 2.5% normal horse serum (Vector
Laboratories, Burlingame, CA) for 30 min was applied
to block the unspecific binding sites. Incubation in
anti-ALIX was performed overnight at 4°C. As control,
cells were incubated with 2.5% normal horse serum
only. Universal ImmPRESS HRP Reagent kit contain-
ing anti-Rabbit/Mouse IgG (MP-7500, Vector
Laboratories, Burlingame, CA) and as chromogen
ImmPact DAB (SK 4105, Vector Laboratories,
Burlingame, CA) were applied according to the manu-
facturer’s instruction. After overnight polymerization
at 60°C (Taab 812), 60 nm ultrathin sections were cut
by a Leica UCT ultramicrotome (Leica Microsystems,
UK) in parallel with the surface of the cells. The ultra-
thin sections were analysed with a Hitachi7100
(Hitachi, Japan) electron microscope equipped by
Veleta, a 2 k × 2 k MegaPixel side-mounted TEM
CCD camera (Olympus). Contrast and brightness of
electron micrographs were edited by Adobe Photoshop
CS3 (Adobe Photoshop Incorporation, CA).
c. For immune EM of released EVs, intact EVs were
enriched by 2,000 g centrifugation. During sample pre-
paration, we have followed the basic protocol described
previously by Visnovitz et al. [12] with minor modifi-
cations. Two to three µL of EV sample in 0.22 µm
filtered PBS was applied onto the surface of a 300
mesh formvar-coated Ni grid and was incubated for
10 min at room temperature. After removal of the
residual solution, EVs were fixed with 0.22 µm filtered
4% paraformaldehyde in PBS (10 min at RT).
Following three washes (5 min, RT) with PBS, 5% of
BSA (Sigma Aldrich) in 0.22 µm filtered PBS was used
for blocking (1 h, RT). Grids were incubated overnight
at 4°C with anti-RAB7 (R8779, mouse) and anti-ALIX
(HPA011905, rabbit) (both in 1:50 in 0.22 µm filtered
5% BSA in PBS). This was followed by washes (three
times 5 min with 0.22 µm filtered 5% BSA).) Secondary
antibodies (polyclonal goat anti-rabbit IgG 10 nm gold
pre-adsorbed (Abcam, Cambridge, UK) and polyclonal
goat anti-mouse IgG 5 nm gold pre-adsorbed (Sigma
Aldrich) were next applied (1:400) for 2 h at RT fol-
lowed by another washes (three times 5 min with
0.22 µm filtered 5% BSA). Samples were then post-
fixed with 2% glutaraldehyde followed by intensive
washes (three times for 5 min with 0.22 µm filtered
5% BSA, three times for 5 min with 0.22 µm filtered
PBS and three times for 5 min with purified water).
Background contrasting was skipped. Before examina-
tion by JEOL 1011 transmission electron microscope
grids, were washed three times with ultrapure water
and dried.
d. Immunoelectron microscopy of HT29 cells.
Fixation and embedding of HT29 cells were performed
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as described previously by Lőrincz et al. [13]. Cells
were fixed with 2%formaldehyde, 0.05% glutaraldehyde
and 0.2% picric acid in PBS (20 min, RT). Following an
intensive wash with 50 mM ammonium chloride and
50 mM glycine, the cells were post-fixed with 1%
uranyl acetate dissolved in 0.05M maleate buffer (3 h,
RT). Cells were dehydrated and embedded in LR white
resin (Sigma Aldrich) according to the manufacturer’s
instructions. Ultrathin sections were treated with 1%
H2O2 (1 min, RT), 0.1% NaBH4, dissolved in TBS
(10 min, RT) and 50 mM glycine dissolved in TBS
(30 min, RT). Sections were blocked with 10% FBS
(1 h RT) and primary anti-RAB7 (R8779, mouse) and
anti-E-cadherin (EP700Y, rabbit) were applied in 1:50
dilutions in 10% FSB in TBS at 4°C, overnight.
Following three intensive washes (5 min, RT) with
10% FBS in TBS secondary antibodies, polyclonal
goat anti-rabbit IgG 10 nm gold pre-adsorbed
(Abcam, Cambridge, UK) and polyclonal goat anti-
mouse IgG 5 nm gold pre-adsorbed (Sigma Aldrich)
were applied in 2% FBS in TBS (2 h, RT). After washes
(2% FBS in TBS three times 5 min and TBS three times
5 min), the samples were post-fixed with 2% glutaral-
dehyde in ultrapure water and stained with 4% uranyl
acetate in 50% methanol (for 15 min) and lead citrate
(for 1 min). Grids were analysed by JEOL 1011 electron
microscope.
Results and discussion
In situ tissue detection of extracellular sevcs in
CRC FFPE sections
Earlier we identified granular ALIX positive cytoplas-
mic structures in CRC histological samples as MVBs
[14]. Here we primarily focused on individual, migrat-
ing CRC cells, because they were easily distinguishable
by the detection of their cytokeratin (CK) intermediate
filaments in the CK negative microenvironment [15].
Furthermore, these cells play a primary role in meta-
static progression [16,17]. Surprisingly, CK positive,
migrating tumour cells (Figure 1a and 1d) show
CD63 and ALIX positive structures protruding from
the cytoplasm into the extracellular space (Figure 1(a–
f)). Figure 1(c) shows the 3D reconstruction of the
surface of a migrating tumour cell also shown in
Figure 1a and 1b. In this 3D reconstruction, the
CD63 positive structures are partially covered by
a thin CK positive layer (Figure 1(c)). Another 3D
reconstruction (Figure 1(f)) reveals the protrusion of
ALIX positive structures from the migrating tumour
cell which is also shown in Figure 1d and 1e. This
phenomenon was also detectable in the marginal cells
of the tumour mass (Supplementary Figure 2A–D).
Importantly, some of the CD63 and ALIX positive
structures were also detected extracellularly, adjacent
to the migrating CRC cells (Figure 1(f)). The 3D exam-
inations confirmed that 85.32% (n = 93/109) of migrat-
ing CRC cells showed the presence of ALIX positive
structures partially or completely outside (but adjacent
to) of the CK positive cytoplasm. Further substantia-
tion of the transit of these structures through the
plasma membrane came from double labelling for
ALIX or CD63 and epithelial (E)-cadherin. This
revealed that the ALIX or CD63 positive structures
were captured on both sides of the E-cadherin positive
plasma membrane and among E-cadherin molecules
(Supplementary Figure 3A–D). In some cases,
a membrane curvature was detectable either above or
below the ALIX or CD63 positive structures at the
plasma membrane-stroma interface (Supplementary
Figure 3E–I).
In selected cases, the 3D reconstruction-based image
analysis defined the exact localization of ALIX and
CD63 positive structures in relation to the cytoplasm
(Supplementary Video 1).
In FFPE samples we did not find significant difference
between the diameters of the ALIX- and CD63 positive
structures at least partial extracellular localization.
However, one has to be aware of the limitations and
inaccuracy of fluorescent measurements [18]. The dia-
meters ranged for ALIX from 0.62 to 1.94 μm, mean±S.
D.: 1.17 ± 0.34 μm and for CD63 from 0.55 to 2.24 μm,
mean±S.D.: 1.20 ± 0.50 μm, respectively (p = 0.27)
(Figure 2a and 2b). Similarly, we could not find
a difference between the number of extracellular (ALIX
mean±S.D.: 2.57 ± 1.62 and CD63 mean±S.D.:
2.18 ± 1.79; p = 0.08; Figure 2d) and intracellular
(ALIX mean±S.D.: 9.50 ± 5.55 and CD63 mean±S.D.:
9.20 ± 7.65, p = 0.74; Figure 2e) structures, respectively.
Further analysis using HyVolution microscopy revealed
that the ALIX positive structures were uneven, showing
small lumps emerging from their surface (Figure 2f and
Supplementary Video 2). STED-microscopy also con-
firmed that these structures were composed of smaller,
distinguishable ALIX-positive spheroids of 98–150 nm
diameter (mean±S.D.: 128.96 ± 16.73 nm; Figure 2a and
2g–j) falling into the size range of sEVs [1]. Based on
these properties, we identified these structures as sEVCs.
Detection of the release of sEVCs in vitro
Figure 3a and 3b show HT29 cell-derived ALIX and
CD63 positive sEVCs localized partly in the cytoplasm,
and partly in the extracellular space. Figure 3c shows
a rare example where a sEVCs hovers on a cytoplasmic
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process. Diameters of the at least partially extracellu-
larly localized, CD63 positive HT29-derived sEVCs
ranged from 0.73 to 2.44 μm (mean±S.D.:
1.34 ± 0.46 μm) and showed an agreement with our
in situ FFPE measurements (p = 0.08) (Figure 2c).
Similarly, the STED microscopic 3D reconstruction
proved that the HT29-derived ALIX positive extracel-
lular structures were sEVCs by demonstration that they
were composed of spheres with ~100-~150 nm in dia-
meter (Figure 3b and 3c inserts). Importantly, indivi-
dual sEVCs were also observed in cell-free zones at
a distance from cultured HT29 cells (Figure 3(d–g)).
This suggested that these structures were released by
cells into the extracellular space. Furthermore, some of
these sEVCs also show positivity for RAB7 (Figure 3
(h–j)), a small GTP-ase which is required for the
maturation of late endosomes/MVBs [19,20] and is
also involved in MVB-derived sEV release [21,22].
EM images also showed that large (from ~500 to
~1500 nm), limiting membrane enclosed sEVCs (sEV
diameter: ~100–170 nm) were associated with the
plasma membrane (Figure 3k) or they were completely
Figure 1. CD63 and ALIX positive protrusions in the cytoplasmic border of migrating colorectal cancer cells (a-b) show the same
cytokeratin (CK, green) positive migrating CRC cell. (b) shows granular CD63 (red) protein expression in the cortical cytoplasm. Scale
bars: 50 μm (a) and 10 μm (b). (c) 3D reconstruction of the same cell as in (a) and (b). CD63 positive structures are present either
partially outside of the cytoplasm (arrowhead) or covered with a thin CK positive layer (white box). (d and e) ALIX (red)/CK (green)
co-immunostaining in another migrating CRC cell. Scale bars: 50 μm (d) and 10 μm (e). (f) shows a 3D reconstruction of the cell
same as in Figure 1(d) and 1(e) with ALIX positive structures (red) which are partially (asterisk) or completely (arrowhead) outside of
CK positive cytoplasm.
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separated from it and were found at different distances
from the cells (Figure 3l). Immune EM of cultures of
HT29 cells showed that sEVCs were covered by
a limiting membrane and showed ALIX positivity
(Figure 3m and 3n). In 2,000 g pellets of the condi-
tioned medium of HT29 cells, limiting membrane-
enclosed sEVCs were detectable (Figure 3(o)), which
also were detected as ALIX/RAB7 double positive sac-
like structures (Figure 3(p)). Based on the presence of
a limiting membrane and RAB7 positivity, we identi-
fied these sEVCs as MVB-like sEVCs.
In our experimental settings, the directionality ofMVB-
like sEVC transit through the plasma membrane of CRC
cells often could not be determined. Thus, theoretically the
MVB-like sEVCs crossing the plasma membrane could be
released either by the tumour or by stromal cells.
Figure 2. Morphology and size distribution of ALIX/CD63 positive sEVs and sEVCs in CRC tissue. (a) Violin plot shows the diameter
distribution of extracellular sEVCs (left) and distinguishable ALIX-positive spheroids inside and close to the sEVCs (right) (measured
with Pannoramic Viewer 1.15.3 and Leica LAS X 3.1.1 software). (b) Comparison of the diameters of the at least partially
extracellularly localized ALIX/CD63 positive structures in migrating CRC cells. (c) Comparison of the diameters of similarly localized
CD63-positive structures in CRC tissues and in HT29 culture. (d) Average number of the at least partially extracellular ALIX-positive
or CD63-positive signals in migrating CRC cells (tissue). (e) Average number of intracellularly localized ALIX-positive or CD63-positive
signals in migrating CRC cells (tissue). B-E shows mean±S.D. of n = 40 cells. HyVolution (f) and STED (g) microscopic images of an
ALIX positive (red) sEVC (white box) which is partially embedded within the CK positive cytoplasm (green) of the migrating CRC cell.
Scale bars: 5 μm and 2 μm respectively. (h) Fluorescence intensity profile of ALIX positive sEVC (red) crossed by a selected line
(green). Scale bar: 1.5 μm. (i) Fluorescence intensity profile and measured Full-Width at Half-Maximum (FWHM) values of a small
group ALIX positive sEVs and (j) a single ALIX positive sEV. Scale bars: 0.2 µm and 0.15 μm (200 nm and 150 nm) respectively. FWHM
values: 141 and 149 nm, respectively.
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Importantly, our in vitro studies with HT29 CRC cell line
(in the absence of stromal cells) showed MVB-like sEVCs
in the conditioned medium providing evidence for the
release of these structures by CRC cells.
Potential mechanisms of MVB-like sEVCs
release
Our data suggest different possible mechanisms by which
MVB-like sEVCs can be released by CRC cells. A potential
mechanism for MVB-like sEVC release is captured in
Supplementary Figure 4A and 4B. Here we found evidence
for the release of blister-like large, membrane enclosed
structures which also contained an MVB (Supplementary
Figure 4B). Supplementary Figure 4D and E suggest
another mechanism for MVB-like sEVC secretion.
A cellular process contains at least two MVBs in
Supplementary Figure 4E. This cell process has
a relatively narrow stalk which may break off to release
MVB-like EVCs along with a portion the cytoplasm
Figure 3. Visualization of extracellular sEVCs in HT29 colorectal carcinoma cell line (a) Confocal (CD63: red, E-cadherin: green), (b) HyVolution
(ALIX: red, E-cadherin: green) and (c) HyVolution (ALIX: red, CK: green) images of HT29 cell-derived sEVCs. Arrowhead points to a cytoplasmic
process in C. Scale bars: 500 nm. The inserts of (b) and (c) show STED microscopic images of the sEVCs (scale bars: 500 nm). (d–g) sEVCs in
cell-free regions of HT29 culture. Scale bar: 50 µm (d). (h-j) ALIX/RAB7 co-staining of extracellular MVB-like sEVCs (arrowheads; scale bars:
5 µm (h), 2 µm (i and j)). (k, l) EM images showMVB-like sEVCs as large, membrane enclosed (arrows) structures close to the cell with internal
vesicles in the size range of sEVs (~100–160 nm). Scale bars: 500 nm. (m, n) Membrane enclosed (arrows) MVB-like sEVCs contain ALIX
positive (DAB staining) spheres close to HT29 cells (inserts). Scale bar: 500 nm and 1 µm, respectively, inserts: 2 µm and 1 µm respectively. (o)
A membrane enclosed (arrow) MVB-like sEVC and (p) an ALIX (5 nm gold)/RAB7 (9 nm GOLD) positive MVB-like sEVC isolated from the
conditioned media of HT29 cells. Scale bars: 500 nm and 200 nm, respectively.
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surrounded by plasma membrane. Supplementary Figure
4G–J show plasma membrane protrusions containing
sEVs. Furthermore, Supplementary Figure 4K shows
a RAB7/E-cadherin double positive cellular protrusion.
Most of the surface of this structure is covered by
a membrane, which gives a smooth contour to the small
EV cluster. Interestingly, on one side, membrane enclosed
small EVs are clearly visible suggesting the discontinuity/
rupture of the limiting membrane. Schematic representa-
tions of the possible release mechanisms are shown in
Supplementary Figures 4C, 4F and 4L.
Plasma membrane rupture as a proposed MVB
secretion mechanism [23] was not detected in our
EM samples. From among the recently described
novel types of EVs [6,7,9], the MVB-like sEVCs
described here show strongest resemblance to the mul-
tivesicular spheres [8]. Of note, overlap of the RAB7
with LC3 protein staining in sEV preparations isolated
from conditioned media (Supplementary Figure 5)
raises the possibility that sEVCs may be released from
HT29 cells by secretory autophagy.
It is obvious that the examined sEVCs are hetero-
geneous in terms of their origin, size and type of their
secretion, thus, further experiments are necessary in
order to classify their subgroups.
In conclusion, the present study demonstrates in situ (in
tissue sections of patients with CRC) for the first time that
migrating carcinoma cells release large, MVB-like sEVCs.
In CRC, MVB-like sEVCs are likely to contribute to the
paracrine regulation of cancer, which effectmaydiffer from
that mediated by conventionally secreted individual sEVs.
Uptake ofMVB-like sEVCsmay have a substantially stron-
ger effect on recipient cells than individual sEVs. In fact, it
has been shown recently that in a somewhat similar sce-
nario, vesicle-cloaked viruses had a disproportionately lar-
ger contribution to infectivity than free individual virus
particles [24]. In addition, due to the possible disruption
of the limiting membrane of the released MVB-like sEVC,
the release of sEVs might lead to a delayed effect to the
microenvironment.
Key aspect of is study is that it may open new
perspectives for fluorescent microscopic analysis of
EV-based communication in archived, formalin-fixed
and paraffin-embedded human tissue samples. The
fixed-embedded human tissue samples provide solid
evidence that the MVB-like sEVC release described in
this article is a non-negligible process that takes place
in human tumour tissues in vivo.
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